Therapeutic Intervention Feasible for Preventing Rheumatoid Arthritis in Patients at Risk
FRIDAY, Feb. 23, 2024 -- Therapeutic intervention with abatacept is feasible for patients at risk for rheumatoid arthritis, according to a study published online Feb. 13 in The Lancet.
Andrew P. Cope, M.D., from King ' s College London, and...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Abatacept | Arthritis | Orencia | Pharmaceuticals | Rheumatoid Arthritis | Rheumatology | Study